Prevalence of goiter and thyroid nodular disease in patients with class III obesity;Prevalência de bócio e doença nodular tireoidiana em pacientes com obesidade grau III

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 57, Issue 2, 2013, Pages 120-125

  de Sousa, Priscila Alves Medeiros ^a   Vaisman, Mario ^a   Carneiro, João Regis Ivar ^a   Guimarães, Lorena ^a   Freitas, Heloisa ^a   Pinheiro, Maria Fernanda Castellar ^b   Liechocki, Sally ^c   Monteiro, Clarissa Menezes Maya ^c   Teixeira, Patrícia de Fátima dos Santos ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Sergio Franco Medicina Diagnóstica   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Goiter; Insulin resistance; Obesity; Thyroid nodule

Indexed keywords

LEPTIN; THYROTROPIN;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; GOITER; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MORBID OBESITY; PREVALENCE; THYROID NODULE;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; GOITER; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; OBESITY, MORBID; PREVALENCE; THYROID NODULE; THYROTROPIN;

EID: 84875425283     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302013000200004     Document Type: Article

References (19)

1. Porto MCV, Brito IC, Calfa ADF, Amoras M, Villela NB, Araújo MB. Perfil do obeso classe III do ambulatório de um hospital universitário em Salvador, Bahia. Arq Bras Endocrinol Metabol. 2002;46:668-73.
2. Rezzónico JN, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord. 2009; 7(4):375-80.
3. Rezzónico J, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid. 2008;18(4):461-4.
4. Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodinedeficient area. Eur J Endocrinol. 2009;161(4):599-605.
5. Mijovi T, How J, Pakdaman M, Rochon L, Gologan O, Hier MP, et al. Body mass index in the evaluation of thyroid cancer risk. Thyroid. 2009;19:467-72.
6. Rotondi M, Cappelli C, Magri F, Botta R, Dionisio R, Iacobello C, et al. Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2011;75(3):378-81.
7. Rezzónico J, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab Syndr Relat Disord. 2011;9:69-75.
8. Rotondi M, Cappelli C, Leporati P, Chytiris S, Zerbini F, Fonte R, et al. A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid disease in patients with morbid obesity. Eur J Endocrinol. 2010;163(1):105-9.
9. Fernández-Real JM, López-Bermejo A, Castro A, Casamitjana R, Ricart W. Thyroid function is intrinsically linked to insulin sensitivity and endothelium dependent vasodilation in healthy euthyroid subject. J Clin Endocrinol Metab. 2006;91:3337-43.
10. Miyakawa M, Saji M, Tsushima T, Wakai K, Shizume K. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin like growth factor 1 levels. J Clin Endocrinol Metab. 1988;67:973-8.
11. Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG, et al. Thyroid functions in humans with morbid obesity. Thyroid. 2006;16:73-8.
12. Position Statement: Standards of Medical Care in Diabetes - 2012. Diabetes Care. 2012;5(Suppl. 1):S11-63.
13. Milech A, Angelucci AP, Golbert A, et al. Metodos e critérios para o diagnóstico de diabtes mellitus. In: Gomes MB, Lerario AC, editors. Diretrizes da Sociedade Brasileira de Diabetes 2009/Sociedade Brasileira de Diabetes. 3th ed. São Paulo: A. Araújo Silva Farmacêutica; 2009. p. 18-20.
14. Vella V, Sciacca L, Pandini G, Mineo R, Squatrito SVigneri R, et al., The IGF system in thyroid cancer: new concepts. Mol Path. 2001;54:121-4.
15. Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC. Volumetric analysis of thyroid lobes by real time ultrasound. Dtsch Med Wochenschr. 1981;41:1338-40.
16. Cheung NW, Boyages SC. Increased incidence of neoplasias in females with acromegaly. Clin Endocrinol. 1997;47:323-7.
17. Ruchala M, Skiba A, Gurgul E, Uruski P, Wasko R, Sowinski J. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer. Neuro Endocrinol Lett. 2009;30:382-6.
18. Cappelli C, Pirola I, Mittempergher F, De Martino E, Casella C, Agosti B, et al. Morbid obesity in women is associated to a lower prevalence of thyroid nodules. Obes Surg. 2012;22(3):460-4.
19. Zimmermann-Blesing T, Brabant G, Holst JJ, Feldt-Rasmussen U. Circulation leptin and thyroid dysfunction. Eur J Endocrinol. 2003;149:257-71.